ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: All together our data suggest that BCR/ABL-OOF is actively involved in the BCR/ABL signalling due to its specific oncogenic properties and it could provide additional targets for developing new drugs in order to eradicate CML stem cells.